Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Gossamer Bio Inc
GOSSCurrent price
0.77 USD
-0.04 USD (-4.94%)
Last closed
0.82 USD
Company
www.gossamerbio.com
ISIN
US38341P1021
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
198 830 912 USD
Yield for 12 month
-5.02 %
1Y
3Y
5Y
10Y
15Y
GOSS
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary arterial hypertension (PAH) in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony-stimulatin factor 1 receptor and c-KIT inhibitor, which is in Phase 3 clinical trial for the treatment of PAH. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. Gossamer Bio, Inc. was incorporated in 2015 and is headquartered in San Diego, California. Address: 3013 Science Park Road, San Diego, CA, United States, 92121
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
6.72 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
+95 842 000 USD
Last Quarter
–
Current Year
-4 385 000 USD
Last Year
-4 429 000 USD
Current Quarter
+94 850 000 USD
Last Quarter
-986 000 USD
Key Figures GOSS
1 year
3 years
5 years
10 years
EBITDA
-61 801 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-11.24 %
PEG Ratio
–
Return On Equity TTM
-90.26 %
Wall Street Target Price
6.72 USD
Revenue TTM
105 322 000 USD
Book Value
0.24 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-0.19 USD
Diluted Eps TTM
-0.19 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-68.03 %
Dividend Analytics GOSS
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History GOSS
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation GOSS
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
0.4585
Price Sales TTM
1.8878
Enterprise Value EBITDA
-0.3927
Price Book MRQ
2.4477
Financials GOSS
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators GOSS
For 52 weeks
0.5 USD
1.6 USD
50 Day MA
0.94 USD
Shares Short Prior Month
7 752 737
200 Day MA
0.94 USD
Short Ratio
7.56
Shares Short
6 952 673
Short Percent
3.17 %
BeatStart